Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
South America Argentina North America

Mexico and Argentina To Cut Burden for Pharma By Swapping GMP Reports

  • News

Executive Summary

Medicines regulators in Mexico and Argentina have agreed to exchange good manufacturing practices inspection certificates.

You may also be interested in...



Will Mexico's COFEPRIS Dissolve Under New Presidency?

Newly inaugurated Mexican President Andrés Manuel López Obrador may restructure drug regulator in quest to centralize government's public health services.

PIC/S To Guide Member Inspectorates On Harmonizing GMP Deficiency Classifications

Draft guidance soon will help the world’s leading pharmaceutical inspectorates align views on which drug GMP deficiencies are considered major – and which are truly critical.

Mexican, Turkish And Iranian Inspectors Become Latest Members Of PIC/S

Mexico, Turkey and Iran will start participating in the international Pharmaceutical Inspection Cooperation Scheme as of January 2018. Meanwhile, Russia has become the latest country to apply to join the scheme.

Table

View full table

Topics

Tags:
South America Argentina North America
Latest Headlines

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

See All
UsernamePublicRestriction

Register

PS124221

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By